Article Details
Retrieved on: 2025-04-14 19:24:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
While Roche had licensed nonexclusive rights to Amgen, the drugmaker feared that Roche might offer the same deal to biosimilar makers once Enbrel's ...
Article found on: www.law360.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here